Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.
-
- STATUS
- Not Recruiting
-
- participants needed
- 40
-
- sponsor
- Relife S.r.l.
Summary
The scope of this open label clinical trial is to evaluate and confirm the performance of Papix acne scar in the prevention and improvement of acne scars in subject suffering for mild to moderate acne. The product will be applied for 8 consecutive weeks and 3 clinical follow up visits will be performed.
Description
The scope of this open label clinical trial is to evaluate and confirm the performance of Papix acne scar in the prevention and improvement of acne scars in subject suffering for mild to moderate acne. The product will be applied for 8 consecutive weeks, 2 times per day into the face.
The dermatologist will perform 3 clinical follow up visits to assess the efficacy and safety of the product.
Details
| Condition | Acne, Scars |
|---|---|
| Age | 12years or above |
| Treatment | Papix acne scar |
| Clinical Study Identifier | NCT04806594 |
| Sponsor | Relife S.r.l. |
| Last Modified on | 6 August 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.